| Start: | Sep 29, 2021 - 2:30 pm |
| End: | Sep 29, 2021 - 5:00 pm |
| Venue: | Webinar |
| Event website: | http://urlr.me/1pGMm |
Dear ETPN members,
we warmly encourage you to participate in the last symposium of the NEW DEAL project “Design & validation of future innovative biotherapies in Inflammatory Bowel Disease” which will happen on September 29, 2021, starting at 2:30PM (CET).
The experts Prof. Gehrard Rogler, Dr. Giriya Goral and the coordinator of the NEW DEAL Project Fabrice Navarro will explore and discuss together future biotherapies in IBD.
REGISTER FOR FREE BY CLICKING ON THIS LINK.
About NEW DEAL
The H2020 NEW DEAL project aims to develop a highly selective and local therapy with an improved efficacy and safety profile for IBD patients. This treatment might be an alternative to the existing therapies.
The use of nanotherapy based on siRNA, targeting specifically the molecular JAK1/JAK3, is a new approach to treat inflammatory bowel diseases. This innovative medicine will deliver a targeted and local therapy directly to the inflamed gut, through the gastrointestinal tract.